Filing Flows › Cryoport (CYRX) › Q1 2026
Cryoport (CYRX) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 5, 2026
Cryoport (CYRX) reported revenue of $47.8M for the first quarter 2026 (Q1 2026), +16% from a year earlier and +5% from the quarter before. Operating margin was -20.1%, net loss $10.5M (22.1% of revenue).
Cryoport, Q1 2026: revenue $47.8M (+16% year over year), operating margin -20.1%, net loss $10.5M, operating cash flow $3.7M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $47.8M | +5% | +16% |
| Operating profit | −$9.6M | — | — |
| Net earnings | −$10.5M | — | — |
| Operating cash flow | $3.7M | +306% | — |
What changed
Revenue was $47.8M in Q1 2026, up 16% year over year and up 5% from the previous quarter. BioLogistics Solutions was the largest line at 45% of revenue. BioLogistics Solutions added $3.1M year over year (up 17%), 46% of the total change.
Gross margin was 45.8%, up 0.4 points from Q1 2025. Operating costs exceeded revenue by $9.6M, an operating margin of -20.1%. Operating expenses grew 22% against revenue growth of 16%. The fastest-growing cost line was SG&A (+26%). The quarter ended with a net loss of $10.5M, narrower than the previous quarter's $11.6M loss.
Operating cash flow was $3.7M. Non-cash charges added back $6.4M of depreciation and amortization and $2.4M of share-based compensation. Working capital and other items added $5.5M. Capital expenditures of $10.0M exceeded it, leaving free cash flow of −$6.2M.
Questions
What was Cryoport's revenue in the first quarter 2026?
Cryoport (CYRX) reported revenue of $47.8M for the first quarter 2026 (Q1 2026), +16% from a year earlier and +5% from the quarter before.
Was Cryoport profitable in the first quarter 2026?
Operating loss was $9.6M (-20.1% of revenue) and net loss $10.5M.
Source: Cryoport 10-Q on SEC EDGAR.